A new research has revealed that Nonalcoholic Fatty Liver Disease (NFLD) is a frequent finding problem in type 2 diabetes patients, but most of the time either this is neglected or goes unnoticed.
The investigators used non-invasive imaging techniques to estimate liver fat and liver stiffness in multiple diabetes patients and observed the prevalence of NAFLD 65 percent in type 2 diabetes patients.
Dr. Rohit Loomba, the author of the study, said that screening asymptomatic diabetics could help prevent advanced liver damage and reduce liver-related complications and deaths.
The research is published in Alimentary Pharmacology and Therapeutics journal.